| (210) | Number of the EPO application | 17863293 |
| (220) | Filing date of the EPO application | 2017.11.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 31/2020, 2020.07.29 |
| (110) | EPO patent number | 3407709 |
| (21) | Number of the application | e 2018 1169 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS INC., US; |
| (72) | Name(s) of inventor(s), code of the country | GUO Chunguang, US;
HARRIS Faith, US;
VORONINA Vera, US;
MCWHIRTER John, US;
LEVENKOVA Natasha, US;
MACDONALD Lynn, US;
TU Naxin, US;
MURPHY Andrew J., US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS INC., US; |
| (54) | Title of the invention | NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A01K 67/027 (2006.01.01); C12N 15/90 (2006.01.01); C12N 15/85 (2006.01.01); C07K 16/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.01.31 |
| (30) | Priority | 201662417845 P, 2016.11.04, US; 201762567932 P, 2017.10.04, US |
| (86) | International application | PCT/US2017/060006, 2017.11.03 |
| (87) | International publication | WO 2018/128691, 2018.07.12 |